BE Board:Archives Academic Industrial Seminar Series

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(New page: {{Template:BE Board}} <div style="padding: 10px; width: 720px; border: 5px solid #2D9258;"> ==2004-2005== *September 23, 2005 - * Special Bioethics Seminar * [http://www.holycross.edu/d...)
Current revision (20:30, 28 October 2011) (view source)
 
Line 2: Line 2:
{{Template:BE Board}}
{{Template:BE Board}}
<div style="padding: 10px; width: 720px; border: 5px solid #2D9258;">
<div style="padding: 10px; width: 720px; border: 5px solid #2D9258;">
 +
 +
==Back to [[BE_Board:Archives_Academic | Academic Archives]] page==
 +
==2004-2005==
==2004-2005==

Current revision

For current website see begradboard.mit.edu

Back to Academic Archives page

2004-2005

  • September 23, 2005 - * Special Bioethics Seminar *

Stempsey (College of Holy Cross)

  • October 28, 2005 - * Special Bioethics Seminar *

Thomas Shannon (Worcester Polytechnic Institute)

  • December 2, 2005

Mark Trusheim (Massachusetts Biotechnology Council) - 56-114 1:30 - 2:30 pm

  • July 22, 2005

Dr. Paul Mason (Genzyme) "Drug discovery at Genzyme"


  • June 10, 2005

Dr. Gyan Bhanot (IBM Life Sciences) "Systems biology and supercomputing at IBM Life Sciences"


  • May 20 , 2005

Dr. Damon Demady (Biogen Idec) "Challenges of drug development: By the book vs. reality"


  • April 22, 2005

Dr. Jinping Gan (Bristol-Myers Squibb) "Reactive metabolites in drug discovery"


  • April 15, 2005

John Essigmann (MIT BE & CEHS) "De-mystification of the grant application process for new academic investigators"


  • April 8, 2005

Nancy Briefs (President & CEO of Percardia) "A long winding road: From patent to PMA"


  • March 25, 2005

Dr. Can Ozbal (BioTrove Inc.) "Mass spectroscopy-based label-free ultra-high throughput screening for drug discovery"


  • March 11, 2005

Dr. Jonathan Gertler (Adams Harkness) "Market dynamics & financial strategies in life science technologies"


  • February 25, 2005

Dr. Cindy Xia (Millenium) "From ABC to SLC: Evaluation of drug transporters in drug discovery and development"


  • February 11, 2005

Dr. Keith Hoffmaster (Pfizer Inc.) "ADME in drug discovery & cholestasis as a mechanism of hepatotoxicity"


  • December 13 , 2004

Drs. Birgit Schoeberl & Brian Harms (Merrimack Pharmaceuticals Inc.) "Starting a career in industry as an MIT alum"


  • November 22, 2004

Dr. Vicki Sato (President of Vertex Pharmaceuticals Inc.) "Careers in academia & in industry"


  • October 5, 2004 (see picture :))

Prof. Michael Lysaght (Brown University) "After the PhD: Career decisions in biomedical engineering"

Personal tools